期刊文献+

Sorcin表达受抑乳腺癌多药耐药细胞株MCF-7/A02对化疗药物敏感性的观察 被引量:1

Influence of knock-down of Sorcin expression to multidrug resistance of human breast cancer cell line MCF-7/A02
下载PDF
导出
摘要 目的观察可溶性耐药相关钙结合蛋白基因(Sorcin)表达受抑乳腺癌多药耐药细胞株MCF-7/A02对化疗药物敏感性的影响,并探讨其机制。方法将MCF-7/A02细胞分为两组,观察组转染针对Sorcin基因的siRNA,对照组不转染。MTT法检测细胞对阿霉素(ADR)、依托泊苷(VP-16)、高三尖杉酯碱(HHT)、长春新碱(VCR)的敏感性,用流式细胞仪检测细胞对碱性蕊香红-123(Rho-123)的外排功能及VP16处理后的细胞凋亡率,Western blot法检测细胞中的Bcl-2、Bax蛋白。结果观察组ADR、VP-16、HHT、VCR的IC50分别为(19.92±1.29)(、31.47±2.36)(、4.19±0.27)(、2.96±0.23)μg/ml,对照组分别为(111.57±5.60)(、144.77±20.43)(、24.30±0.43)、(5.89±0.28)μg/ml,两组比较,P均<0.01。观察组细胞凋亡率为9.15%±0.25%,对照组为4.10%±0.12%,两组比较,P<0.01。观察组细胞内Rho-123的荧光强度为6.34±0.86,对照组为5.42±0.73,两组比较,P>0.05。观察组细胞中Bcl-2、Bax蛋白表达量为0.59±0.0321、.80±0.03,对照组分别为0.69±0.025、1.94±0.04,两组比较,P均<0.05。结论抑制Sorcin表达可显著增强MCF-7/A02细胞对化疗药物的敏感性;这种作用可能与其调节Bcl-2/Bax通路促进MCF-7/A02细胞凋亡有关。 Objective To study the effect of soluble resistance-related calcium-binding protein gene (Sorcin) on multidrug resistance (MDR) in MCF-7/A02 cells, and explore the correlative mechanisms. Methods MCF-7/A02 cells were divided into observe group (transfected with Sorcin gene siRNA) and control group (non-transfection). The expression of Sorcin and proteins of Bcl-2, Bax were measured by western blot after siRNA transfection in MCF-7/A02 ceils. The sensitivity of cells to ADR, VP-16, HHT and VCR were measured by MTT assays. The accumulation of cytotoxic agents in cells and the apoptotic rate to VP-16 after siRNA transfection were detect by FACS. Results The ADR, VP-16, HHT, VCR IC5o of the observe group were ( 19.92 ± 1.29), (31.47 ± 2.36 ), (4.19 ± 0.27 ), (2.96 ± 0.23 ) μg/ml, control group were ( 111.57 ± 5.60), ( 144.77 ± 20.43 ), (24.30 ± 0.43 ), ( 5.89 ± 0.28 ) pLg/ml, all P 〈 0.01. Apoptosis rate of the treatment group was 9.15% ± 0.25% , control group was 4.10% ± 0.12%, P 〈 0.01. The cells MFI of observe group was 6.34 ± 0.86, control group was 5.42 ± 0.73, P 〉 0.05. Bcl-2/GAPDH, Bax/GAPDH light density ratio of the treatment group was 0.59 ± 0.03 and 1.80 ± 0.03, control group was 0.69 ± 0.20 and 1.94 ± 0.04, all P 〈 0.05. Conclusion The reduction of the expression of Sorcin leads to partly reversion of MDR phenotype in MCF-7/A02 cells, which is associated with the changes of Bcl-2 and Bax expression.
出处 《山东医药》 CAS 北大核心 2011年第34期1-3,共3页 Shandong Medical Journal
基金 教育部高等学校博士点基金资助项目(20070023016)
关键词 可溶性耐药相关钙结合蛋白基因 多药耐药 Bcl-2基因 BAX基因 乳腺癌 Sorcin muhidrug resistance Bcl-2 gene Bax gene breast cancer
  • 相关文献

参考文献10

  • 1Molinari A, Calcabrini A, Meschini S, et al. Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells[J]. Curt Protein Pept Sci,2002,3(6) :653-670.
  • 2Gomez-Marttnez A, Garcta-Morales P, Carrato A, et al. Post-tran- scriptional regulation of P-glycoprotein expression in cancer cell lines[J]. Mol Cancer Res, 2007,5(6) :641-653.
  • 3Kang DI, Kang HK, Gwak HS, et al. Liposome composition is im- portant for retention of liposomal rhodamine in P-glycopretein-over- expressing cancer ceils [ J ]. Drug Deliv,2009,16 ( 5 ) : 261-267.
  • 4Fojo T, Bates S. Strategies for reversing drug resistance[ J]. Onco- gene, 2003,22(47) :7512-7523.
  • 5Ullah MF. Cancer muhidrug resistance (MDR) : a major impedi- ment to effective chemotherapy [ J ]. Asian Pac J Cancer Prey, 2008, 9(1) :1-6.
  • 6Lee CH. Reversing agents for ATP-binding cassette (ABC) trans- porters: appli-cation in modulating multidrug resistance (MDR) [ J ]. Curr Med Chem Anticancer Agents, 2004, 4 ( 1 ) :43-52.
  • 7Liscovitch M, Lavie Y. Cancer multidrug resistance: a reviw of re- cent drug discovery research[J]. IDrugs, 2002, 5(4) :349-355.
  • 8Polgar O, Robey RW, Bates SE. ABCG2 : structure, function and role in drug response [ J ]. Expert Opin Drug Metab Toxieol, 2008, 4(1) :1-15.
  • 9Luqmani YA. Mechanisms of drug resistance in cancer chemothera- py[ J ]. Med Princ Pract, 2005, 14 ( Suppl 1 ) :35-48.
  • 10Pallis M, Turzanski J, Higashi Y, et al. P-glyeoprotein in acute myeloid leukemia:therapeutic implications of its association with both muhidrug-resistant and apoptosis-resistant phenotype [ J ]. Leuk Lymphoma,2002,43 (6) : 1121-1228.

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部